Trials / Completed
CompletedNCT00073554
Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion
A Phase 2, Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Activity of Alfimeprase in Patients With Acute Peripheral Arterial Occlusion
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (planned)
- Sponsor
- ARCA Biopharma, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial is for patients with acute occlusion of one of the arteries supplying blood to the leg. The trial is designed to determine the safety and activity of a novel clot dissolving (thrombolytic) drug (alfimeprase).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alfimeprase |
Timeline
- Start date
- 2003-06-01
- First posted
- 2003-11-26
- Last updated
- 2009-12-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00073554. Inclusion in this directory is not an endorsement.